6-minute daily habit could help Ozempic users preserve muscle, expert says
A 40-week study found that resistance training helped people taking tirzepatide lose 25% less lean tissue while improving strength by 10%.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Coverage regarding GLP-1 medications focused on related muscle loss claims, nutrient deficiencies, and strategies such as resistance training or daily habits to preserve muscle mass. Following the initial reporting, the story quieted without a definitive conclusion in the coverage.
Epilogue added 2d ago, after coverage quieted.
The brief
A randomized controlled trial published in Nature Medicine found that resistance training preserves lean and muscle mass and increases strength in people taking the GLP-1 weight-loss drug tirzepatide, sold as Mounjaro. Medical Xpress reported on the Tirzepatide and Resistance Exercise (T-REx) study, led by Winthrop Professor Danny Green of The University of Western Australia's School of Human Sciences and HealthSpan Institute. Green said resistance exercise should be part of the prescription when people use a weight-loss drug such as tirzepatide.
The study followed 120 men and postmenopausal women aged 50 to 70 who were obese, or overweight with a weight-related health issue, but without type 2 diabetes. All were prescribed tirzepatide for weight management. Half took part in three sessions of resistance training each week, and all participants received general advice on hydration, protein, and fiber intake.
Both groups lost a similar amount of weight. The trained group lost an average of 22.28 kg (49.1 pounds), while the untrained group lost 22.61 kg (49.8 pounds) after 40 weeks. Fat loss was also comparable, with the trained group losing 17.98 kg (39.6 pounds) and the untrained group losing 17.19 kg (37.9 pounds).
The key difference was in lean tissue and strength. Participants who did resistance training lost 25% less lean tissue, including muscle, than those who did not. Upper- and lower-body strength improved by 10% in the resistance training group, while it declined by 10% in the group that did not train.
Green said loss of lean mass, including muscle, is an inevitable part of weight loss by any method, whether through diet and exercise alone or medical or surgical interventions. He noted that GLP-1 medicines reduce body weight by an average of 20% to 25%, and more in many people, making it crucial to understand how to achieve optimal body composition and health in the weight-reduced state. He said the goal for those taking weight-loss drugs should be to improve health and function, not just a lower number on the scale.
The headlines frame the finding as a six-minute daily habit that could help Ozempic users preserve muscle, citing an expert. The source text itself describes three weekly resistance training sessions rather than a six-minute daily routine, and it focuses on tirzepatide rather than semaglutide, the active ingredient in Ozempic and Wegovy. Medical Xpress said the study is the first to show the effects of combining a GLP-1 medicine and resistance training on body composition, muscle mass, strength, and a range of cardiovascular health measures.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4d ago.
Quick answers
What did the T-REx study find about resistance training and GLP-1 weight-loss drugs?
Participants taking tirzepatide who did resistance training lost 25% less lean tissue, including muscle, than those who did not, and their upper- and lower-body strength improved by 10% while it declined by 10% in the untrained group.
How much weight did participants lose in the study?
The trained group lost an average of 22.28 kg (49.1 pounds) and the untrained group lost 22.61 kg (49.8 pounds) after 40 weeks.
Who led the study and where was it published?
Winthrop Professor Danny Green of The University of Western Australia led the study, which was published in Nature Medicine.
Coverage (20)
- 6-minute daily habit could help Ozempic users preserve muscle, expert says New York Post · 8d ago
- One Nutrient Could Help You Hold On To Muscle While On GLP-1s MindBodyGreen · 8d ago
- 8 things to consider before taking a GLP-1 medication KSAT · 8d ago
- Muscle Loss From GLP-1 Drugs May Not Start in the Muscle Dr. Axe · 8d ago
- GLP-1s Are Dramatically Linked to Deficiency in This One Essential Nutrient Men's Health · 8d ago
- Medical Weight Loss Explained by Medical Weight Loss Expert Susan Stivalo in HelloNation Article on Medications and How They Work PR Newswire · 8d ago
- The GLP-1 Muscle Loss Claim: What's True, What's Not Medscape · 8d ago
- Resistance training key to maintaining muscle function during GLP-1 weight loss, study shows Medical Xpress · 8d ago
- GLP-1s Are Dramatically Linked to Deficiency in This One Essential Nutrient AOL.com · 8d ago
- Shocking finding about weight loss drugs News.com.au · 8d ago
- GLP-1s Are Dramatically Linked to Deficiency in This One Essential Nutrient Yahoo Health · 8d ago
- You lost weight on a GLP-1, but are you really healthy? NewsNation · 8d ago
- Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial Nature · 8d ago
- You lost weight on a GLP-1, but are you really healthy? Yahoo Health · 8d ago
- ‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s SMH.com.au · 8d ago
- GLP-1 weight-loss drugs may change what you crave, not just how much you eat News-Medical · 8d ago
- MASTER CLASS: Best weight loss prescription is to change behavior The Arkansas Democrat-Gazette · 8d ago
- GLP-1 medications bring hope, risks and lawsuits AZ Big Media · 8d ago
- Hair loss, nail changes and rare vision problems: Understanding the risks of GLP-1 drugs Straight Arrow · 8d ago
- 6-minute daily habit could help Ozempic users preserve muscle, expert says Fox News · 8d ago
Topics
Related trends
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Taking GLP-1s forever? 5 strategies to keep weight off if you stop
New Cleveland Clinic research maps five evidence-based exit strategies for patients discontinuing GLP-1 weight-loss drugs, a question facing millions as supply and cost pressures mount.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Nearly half of U.S. GLP-1 users are altering prescribed dosing, with cost and side effects driving widespread non-adherence.
Hundreds of children in England prescribed weight-loss jabs, figures show
New figures reveal hundreds of children in England, including under-12s, have been prescribed weight-loss jabs.
Makers of obesity drugs hit back at claims of negative side effects
Makers of obesity drugs defend their product safety amid mounting public scrutiny and reports of side effects.